| Allissa Wendell, MS CCC-SLP | |
|
303 Jefferson Ave, Fairport, NY 14450-2313 | |
| (585) 967-4134 | |
| Not Available |
| Full Name | Allissa Wendell |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 303 Jefferson Ave, Fairport, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114321452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 024226-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Allissa Wendell, MS CCC-SLP 303 Jefferson Ave, Fairport, NY 14450-2313 Ph: () - | Allissa Wendell, MS CCC-SLP 303 Jefferson Ave, Fairport, NY 14450-2313 Ph: (585) 967-4134 |
News Archive
"Across large parts of Japan stricken a week ago by a quake and tsunami, aid isn't getting through. Blizzards, impassible roads, worries over radiation exposure, fuel shortages and other logistical problems have stalled aid from getting to those who need it, even as officials have boosted the amount of food and other goods available to some easier-to-reach communities," the Wall Street Journal reports.
New research into the fight against Dengue, an insect-borne tropical disease that infects up to 390 million people worldwide annually, may influence the development of anti-viral therapies that are effective against all four types of the virus.
Using a blood test, a German-Dutch research team has predicted the risk of Alzheimer's disease in people who were clinically diagnosed as not having Alzheimer's disease but who perceived themselves as cognitively impaired (Subjective Cognitive Declined, SCD).
The London School of Hygiene & Tropical Medicine (LSHTM) will play a key role in a new Centre for Care that will support reform within the care system by providing research and evidence that can guide decision making and practice.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, and Patheon Inc., a global provider of drug development and manufacturing services, announced today a long-term agreement for commercial manufacturing of Contrave® (naltrexone HCL sustained release (SR)/bupropion HCL SR) as well as development of future formulations of Orexigen products.
› Verified 9 days ago
Mrs. Corinne A Muller, NYS LIC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Pittsford Palmyra Rd, Suite 320, Fairport, NY 14450 Phone: 585-223-5090 Fax: 585-425-1785 | |
Gretchen Gustavson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 149 N Main St, Fairport, NY 14450 Phone: 585-377-2230 | |
Ms. Laura Schultze Sepka, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 41 Oconnor Rd, Fairport, NY 14450 Phone: 585-377-4660 | |
Mrs. Karen Jeanne Barner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 41 Oconnor Rd, Fairport, NY 14450 Phone: 585-377-4660 | |
Mrs. Everien Rebecca Malone, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 41 Oconnor Rd, Fairport, NY 14450 Phone: 585-377-4660 | |
Toni Mizma, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Pittsford Palmyra Rd, Suite 380, Fairport, NY 14450 Phone: 585-223-5090 Fax: 585-425-1785 | |
Kaitlin Michelle Hurley, M.A. CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 58 Blackwatch Trl, Fairport, NY 14450 Phone: 585-421-8082 |